Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.
Open | $0.705 |
Close | $0.681 |
Volume / Avg. | 364.913K / 696.678K |
Day Range | 0.680 - 0.740 |
52 Wk Range | 0.593 - 1.480 |
Market Cap | $61.802M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 0.22% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cidara Therapeutics (NASDAQ: CDTX) through any online brokerage.
Other companies in Cidara Therapeutics’s space includes: Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Aligos Therapeutics (NASDAQ:ALGS), CollPlant Biotechnologies (NASDAQ:CLGN) and Ocean Biomedical (NASDAQ:OCEA).
The latest price target for Cidara Therapeutics (NASDAQ: CDTX) was reported by HC Wainwright & Co. on Monday, April 8, 2024. The analyst firm set a price target for 6.00 expecting CDTX to rise to within 12 months (a possible 779.77% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $0.682 last updated April 19, 2024 at 7:36 PM EDT.
There are no upcoming dividends for Cidara Therapeutics.
Cidara Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Cidara Therapeutics.
Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.